by Quantro-tx | Apr 30, 2021 | Allgemein
Vienna, Austria, 30 April 2021: QUANTRO Therapeutics GmbH today announced the appointment of Dr. Elmar Maier as Independent Chairman of its Board. Elmar has a long-standing track record as a seasoned dealmaker in the life science industry. Over the last 26 years, he...by Quantro-tx | Apr 19, 2021 | Allgemein
• QUANTRO to enable discovery of novel therapeutics that interfere with disease-causing transcriptional programs in cancer and other diseases. • Transcriptional Fingerprinting to transform high-throughput drug discovery in cell-based compound screening. • QUANTRO...by Quantro-tx | Jul 10, 2020 | Allgemein
Herzog, V., Reichholf, B., Neumann, T., Rescheneder, P., Bhat, P., Burkard, T., Wlotzka, W., von Haeseler, A., Zuber, J. and Ameres, S. (2017). Thiol-linked alkylation of RNA to assess expression dynamics. Nature Methods, 14(12), pp.1198-1204. Muhar, M., Ebert, A.,...by Quantro-tx | Jul 9, 2020 | Allgemein
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est...